Evaluation of potency of the selected bioactive molecules from Indian medicinal plants with MPro of SARS-CoV-2 through in silico analysis

Evaluation of potency of the selected bioactive molecules from Indian medicinal plants with MPro of SARS-CoV-2 through in silico analysis

Background: The recent outbreak of the novel SARS-CoV-2 across the globe and the absence of specific drug against this virus lead the scientific community to look into some alternative indigenous treatments. India as a hub of Ayurvedic and medicinal plants can shed light on its treatment using speci...

Full description

Bibliographic Details
Main Authors:	Pinku Halder, Upamanyu Pal, Pranab Paladhi, Saurav Dutta, Pallab Paul, Samudra Pal, Debasmita Das, Agnish Ganguly, Ishita Dutta, Sayarneel Mandal, Anirban Ray, Sujay Ghosh
Format:	Article
Language:	English
Published:	Elsevier 2022-04-01
Series:	Journal of Ayurveda and Integrative Medicine
Subjects:	SARS CoV-2 virus Mpro In silico molecular docking Phytochemical Indian spices Medicinal plants
Online Access:	http://www.sciencedirect.com/science/article/pii/S0975947621000759

Similar Items

Sterol Constituents of Sea Fan (Gorgonia mariae) as Potential Candidates of MPro Protein SARS-CoV-2 Inhibitor: in silico Study
by: Faruk Jayanto Kelutur
Published: (2022-01-01)

Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro
by: Katarzyna Papaj, et al.
Published: (2021-11-01)

Uji Aktivitas Senyawa Bahan Alam terhadap Enzim Mpro pada SARS-CoV-2 Secara In Silico
by: Syahrul Hidayat, et al.
Published: (2021-12-01)

Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
by: Ísis Venturi Biembengut, et al.

Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach
by: Mycal Dutta, et al.
Published: (2021-05-01)

Advances in the Development of SARS-CoV-2 Mpro Inhibitors
by: Laura Agost-Beltrán, et al.
Published: (2022-04-01)

Understanding etiology of chromosome 21 nondisjunction from gene × environment models
by: Pinku Halder, et al.
Published: (2021-11-01)

Inhibition of SARS-CoV-2 Mpro with Vitamin C, L-Arginine and a Vitamin C/L-Arginine Combination
by: Ivana Đukić, et al.
Published: (2023-01-01)

In Silico Study of Secondary Metabolites in Dendrobium spp. as SARS-CoV-2 Antivirus on Main Protease (Mpro)
by: Anggiresti Kinasih, et al.
Published: (2022-03-01)

Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation
by: Asim Kumar Bepari, et al.
Published: (2021-04-01)

THE POTENTIAL OF CARRAGEENAN FOR THE DRUG DISCOVERY OF COVID-19 VIA MOLECULAR DOCKING WITH ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) AND THE MAIN PROTEASE (MPRO) OF SAR-COV-2
by: Thet, H.A.
Published: (2022-11-01)

Natural phenolic compounds from Satureja L. as inhibitors of COVID-19 protease (Mpro): Computational investigations
by: Faika Başoğlu-Ünal, et al.
Published: (2022-01-01)

Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
by: Srijan Chatterjee, et al.
Published: (2023-06-01)

Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms
by: Julia M Flynn, et al.
Published: (2022-06-01)

Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
by: Matteo Pavan, et al.
Published: (2022-12-01)

Unbinding ligands from SARS-CoV-2 Mpro via umbrella sampling simulations
by: Nguyen Minh Tam, et al.
Published: (2022-01-01)

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020-11-01)

Prevalence of Y chromosome microdeletion in azoospermia factor subregions among infertile men from West Bengal, India
by: Saurav Dutta, et al.
Published: (2021-10-01)

Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro
by: Min Zhang, et al.
Published: (2023-08-01)

The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
by: Mateus Sá Magalhães Serafim, et al.
Published: (2023-07-01)

Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
by: Ting Xiao, et al.
Published: (2021-06-01)

Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid
by: Jonathan T. Lee, et al.
Published: (2022-08-01)

Different Cases of SARS-CoV-2 Infection and Its Impact on Health and Economy with Special Emphasis on Antiviral Drug Targets
by: Hiran Kanti Santra, et al.
Published: (2020-05-01)

Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro
by: Zainab Jan, et al.
Published: (2023-01-01)

Natural Compounds Activities against SARS-CoV-2 Mpro through Bioinformatics Approaches for Development of Antivirus Candidates
by: Taufik Muhammad Fakih
Published: (2021-07-01)

Carvacrol, a Plant Metabolite Targeting Viral Protease (Mpro) and ACE2 in Host Cells Can Be a Possible Candidate for COVID-19
by: Hayate Javed, et al.
Published: (2021-02-01)

Finding potential inhibitors for Main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies
by: N. Anis Ahamed, et al.
Published: (2023-12-01)

Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
by: Ahmad Alzamami, et al.
Published: (2022-04-01)

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
by: Moujane Soumia, et al.
Published: (2020-01-01)

Identification of SARS-CoV-2 Main Protease (Mpro) Cleavage Sites Using Two-Dimensional Electrophoresis and In Silico Cleavage Site Prediction
by: Noémi Miltner, et al.
Published: (2023-02-01)

Exploring the structural and molecular interaction landscape of nirmatrelvir and Mpro complex: The study might assist in designing more potent antivirals targeting SARS-CoV-2 and other viruses
by: Chiranjib Chakraborty, et al.
Published: (2023-12-01)

In silico exploration of Lycoris alkaloids as potential inhibitors of SARS-CoV-2 main protease (Mpro)
by: Fredrick Mutie Musila, et al.
Published: (2022-09-01)

Virtual screening based on the structure of more than 105 compounds against four key proteins of SARS-CoV-2: MPro, SRBD, RdRp, and PLpro
by: Farzan Nabati, et al.
Published: (2022-01-01)

Exploring the Potency of <i>Nigella sativa</i> Seed in Inhibiting SARS-CoV-2 Main Protease Using Molecular Docking and Molecular Dynamics Simulations
by: Ari Hardianto, et al.
Published: (2021-08-01)

The etiology of Down syndrome: Maternal MCM9 polymorphisms increase risk of reduced recombination and nondisjunction of chromosome 21 during meiosis I within oocyte.
by: Upamanyu Pal, et al.
Published: (2021-03-01)

Inhibition of SARS-CoV-2 3CL Mpro by Natural and Synthetic Inhibitors: Potential Implication for Vaccine Production Against COVID-19
by: Anwar Ullah, et al.
Published: (2021-04-01)

Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L
by: Elisa Costanzi, et al.
Published: (2021-10-01)

An understanding of coronavirus and exploring the molecular dynamics simulations to find promising candidates against the Mpro of nCoV to combat the COVID-19: A systematic review
by: Madhur Babu Singh, et al.
Published: (2022-11-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)

Common Indian spices : nutrient composition, consumption and contribution to dietary value /
by: 320022 Pradeep, K. Uma, et al.